Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.
With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.
Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.
Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
Technology used to tag friends on social media could change the way drug discovery is done.
Melanoma survivor T.J. Sharpe discusses the importance of clinical trials to help raise awareness among the community.
Survey results highlight the need for concerted action to guard against a fresh upsurge in the disease.
The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.
One man’s fascination with malaria helps fuel the search for new treatments
The best treatment for multifaceted diseases like NASH may be combinations of drugs.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.